Literature DB >> 28478609

Comparison of nomograms predicting lymph node invasion in patients undergoing radical prostatectomy for prostate cancer.

G J Nason1, E M O'Connor2, D MacMahon3, B Moss2, S W Considine2, A Cahill2, C O'Rourke3, F M O'Brien2,3.   

Abstract

INTRODUCTION: The aim of this study was to compare the performance of preoperative risk nomograms or detecting lymph node invasion in a cohort of men undergoing radical prostatectomy (RP).
METHODS: A retrospective analysis was performed on all men (n = 145) who underwent RP between 2012 and 2015. Preoperative data was inputted to the Memorial Sloan-Kettering Cancer Centre (MSKCC), Partin 2011 and Briganti nomograms and the University of California San Francisco- Centre of the Prostate Risk Assessment tool (UCSF-CAPRA). The risk of lymph node involvement (LNI) was calculated and compared to final histology.
RESULTS: One hundred three (71%) men underwent a lymph node dissection at RP. Ten (9.7%) demonstrated LNI. The median nodal yield was 15 nodes, with no difference between those with LNI and those without (19.5 vs 14.5, p = 0.22).No patient classified as low risk on the UCSF-CAPRA score had evidence of LNI. In patients with LNI, no patient breached the 2% threshold for lymph node dissection (LND) on the MSKCC nomogram; four patients breached the 5% threshold on the Partin tables while three patients breached the 2.5% threshold for the Briganti nomogram.
CONCLUSION: Nomograms produce useful information regarding risk of disease; however, they often have not been validated on different populations. Risk predictions need to be considered carefully and treatment decisions were made on a patient specific basis.

Entities:  

Keywords:  Lymph node dissection; Nomogram; Prostate cancer; Risk assessment

Mesh:

Year:  2017        PMID: 28478609     DOI: 10.1007/s11845-017-1626-8

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  22 in total

1.  Updated nomogram predicting lymph node invasion in patients with prostate cancer undergoing extended pelvic lymph node dissection: the essential importance of percentage of positive cores.

Authors:  Alberto Briganti; Alessandro Larcher; Firas Abdollah; Umberto Capitanio; Andrea Gallina; Nazareno Suardi; Marco Bianchi; Maxine Sun; Massimo Freschi; Andrea Salonia; Pierre I Karakiewicz; Patrizio Rigatti; Francesco Montorsi
Journal:  Eur Urol       Date:  2011-11-07       Impact factor: 20.096

2.  Validation of a nomogram predicting the probability of lymph node invasion among patients undergoing radical prostatectomy and an extended pelvic lymphadenectomy.

Authors:  Alberto Briganti; Felix K-H Chun; Andrea Salonia; Giuseppe Zanni; Vincenzo Scattoni; Luc Valiquette; Patrizio Rigatti; Francesco Montorsi; Pierre I Karakiewicz
Journal:  Eur Urol       Date:  2006-02-17       Impact factor: 20.096

3.  In which patients with prostate cancer should we perform a lymph-node dissection?

Authors:  Markus Graefen
Journal:  Eur Urol       Date:  2006-08       Impact factor: 20.096

4.  Adherence of the indication to European Association of Urology guideline recommended pelvic lymph node dissection at a high-volume center: Differences between open and robot-assisted radical prostatectomy.

Authors:  J Schiffmann; A Haese; Sami-Ramzi Leyh-Bannurah; G Salomon; T Steuber; T Schlomm; K Boehm; B Beyer; A Larcher; U Michl; H Heinzer; H Huland; M Graefen; P I Karakiewicz
Journal:  Eur J Surg Oncol       Date:  2015-06-01       Impact factor: 4.424

5.  Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

Authors:  Igle J de Jong; Jan Pruim; Philip H Elsinga; Willem Vaalburg; Han J Mensink
Journal:  J Nucl Med       Date:  2003-03       Impact factor: 10.057

6.  Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE.

Authors:  Jun Kawakami; Maxwell V Meng; Natalia Sadetsky; David M Latini; Janeen Duchane; Peter R Carroll
Journal:  J Urol       Date:  2006-10       Impact factor: 7.450

7.  Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005.

Authors:  Danil V Makarov; Bruce J Trock; Elizabeth B Humphreys; Leslie A Mangold; Patrick C Walsh; Jonathan I Epstein; Alan W Partin
Journal:  Urology       Date:  2007-06       Impact factor: 2.649

Review 8.  Pelvic lymph node dissection in prostate cancer.

Authors:  Alberto Briganti; Michael L Blute; James H Eastham; Markus Graefen; Axel Heidenreich; Jeffrey R Karnes; Francesco Montorsi; Urs E Studer
Journal:  Eur Urol       Date:  2009-03-10       Impact factor: 20.096

9.  Standard versus limited pelvic lymph node dissection for prostate cancer in patients with a predicted probability of nodal metastasis greater than 1%.

Authors:  Karim Touijer; Farhang Rabbani; Javier Romero Otero; Fernando P Secin; James A Eastham; Peter T Scardino; Bertrand Guillonneau
Journal:  J Urol       Date:  2007-05-11       Impact factor: 7.450

10.  The association between total and positive lymph node counts, and disease progression in clinically localized prostate cancer.

Authors:  Timothy A Masterson; Fernando J Bianco; Andrew J Vickers; Christopher J DiBlasio; Paul A Fearn; Farhang Rabbani; James A Eastham; Peter T Scardino
Journal:  J Urol       Date:  2006-04       Impact factor: 7.450

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.